Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease

Blood Purification

Volumn 26, Issue 5, 2008, Pages 423-428

  Jiang, Na ^a   Qian, Jiaqi ^a   Lin, Aiwu ^a   Lindholm, Bengt ^b   Axelsson, Jonas ^b   Yao, Qiang ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Baxter Renal Asia Pacific

Author keywords

Body mass index; Chronic kidney disease; Dyslipidemia; Glucose exposure; Hyperglycemia

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; C-REACTIVE PROTEIN; DIALYSIS SOLUTIONS; FEMALE; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TRIGLYCERIDES;

EID: 50949131994     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000153248     Document Type: Article

References (29)

1. Sitter T, Sauter M: Impact of glucose in peritoneal dialysis: saint or sinner. Perit Dial Int 2005;25:415-425.
2. Holmes CJ, Shockley TR: Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int 2000;20(suppl 2):37-41.
3. Heimbürger O, Waniewski J, Werynski A, Lindholm B: A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992;41:1320-1332.
4. Bergström J, Fürst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993;44:1048-1057.
5. Grostein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981;19:564-567.
6. Holmes C, Mujais S: Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int 2006;70:S104-S109.
7. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
8. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
9. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, Prins JB, Isbel NM: Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology 2007;12:391-398.
10. Peralta CA, Kurella M, Lo JC, Chertow GM: The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2006;15:361-365.
11. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risks for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005;16:2134-2140.
12. Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bäräny P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006;69:596-604.
13. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III. JAMA 2001;285:2486-2497.
14. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12:1046-1051.
15. Pennell P, Rojas C, Asif A, Rossini E: Managing metabolic complications of peritoneal dialysis. Clin Nephrol 2004;62:35-43.
16. Axelsson J, Moller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P: Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 2006;48:915-925.
17. Panarello G, Calianno G, Baz HD, Signori D, Cappelletti P, Tesio F: Does continuous ambulatory peritoneal dialysis induce hypercholesterolemia? Perit Dial Int 1993;13(suppl 2):421-423.
18. Szeto CC, Chow KM, Kwan CHB, Chung KY, Leung CB, Li KTP. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis, 2007,49:524-532.
19. Oda H, Keane WF: Lipid abnormalities in end-stage renal disease. Nephrol Dial Transplant 1998;13(suppl 1):45-49.
20. Breckenridge WC, Roncari DAK, Khanna R, Oreopoulos DG: The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins. Atherosclerosis 1982,45:249-258.
21. Lindholm B, Norbeck HE: Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 1986,220:143-151.
22. Johansson AC, Samuelsson O, Attman PO, Haraldsson B, Moberly J, Knight-Gibson C, Alaupovic P: Dyslipidemia in peritoneal dialysis - relation to dialytic variables. Perit Dial Int 2000;20:306-314.
23. Sisca S, Maggiore U: Beneficial effect of icodextrin on the hypertriglyceridemia of CAPD patients. Perit Dial Int 2002;22:727-729.
24. Furuya R, Odamaki M, Kumagai H, Hishida A: Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients. Nephrol Dial Transplant 2006;21:494-498.
25. Kwan BC, Murtaugh MA, Beddhu S: Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol 2007;2:992-998.
26. Ingelsson E, Hulthe J, Lind L: Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 2008;38:502-509.
27. Suliman ME, Stenvinkel P: Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi J Kidney Dis Transpl 2008;19:329-345.
28. Francesco L, Daniele M, Ferruccio C, Marco DA, Lucia DV, Aurelio L, Fabio M, Donatella S: Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001;12:2411-2417.
29. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K: Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 2007;18:293-303.